However, this popularity has often outpaced the actual clinical evidence, creating a significant gap between laboratory enthusiasm and evidence-based claims about human application

Disclosures: Peter Lymberopoulos: Nothing to Disclose, Raphael Kirou: Nothing to Disclose, Anwar Uddin: Nothing to Disclose, Aboud Kaliounji: Nothing to Disclose, Anjiya Shaikh: Nothing to Disclose, Madeleine Hines Salge: Nothing to Disclose, Patrick Boddie: Nothing to Disclose, Vinh Tran: Nothing to Disclose, Howard (Tzu-Hao) Lee: Nothing to Disclose, Kavish Patidar: Madrigal Pharmaceuticals: Medical Advisory Board, Fasiha Kanwal: Nothing to Disclose, Anji Wall: Nothing to Disclose, Abbas Rana: Nothing to Disclose, George Cholankeril: Nothing to Disclose 1425 FRAILTY AND SARCOPENIA PREDICT PERI-OPERATIVE OUTCOMES IN PATIENTS UNDERGOING LIVER TRANSPLANTATION: ANALYSIS OF NATIONAL INPATIENT SAMPLE 2016-2020 Aalam Sohal 1 Sheena Bhushan 1 Isha Kohl 2 Srinivasan Dasarathy 3 Kris Kowdley 4 , 1 Liver Institute Northwest, Seattle, WA, 2 Department of Public Health, Icahn School of Medicine, Mount Sinai, New York, NY, 3 Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH, 4 Liver Institute Northwest Background: Frailty and sarcopenia contribute to adverse clinical outcomes in patients with cirrhosis awaiting and after liver transplantation (LT)

Other topics discussed include how heat versus cold impacts neurons and wounds, red-light, sunlight, stem cells and more
One of its key functions is its involvement in the enzyme glutathione peroxidase, which works in tandem with glutathione to neutralize free radicals and reduce oxidative damage